Laboratorio Reig Jofre Stock

Laboratorio Reig Jofre ROA 2025

Laboratorio Reig Jofre ROA

0.03

Ticker

RJF.MC

ISIN

ES0165359029

WKN

A140EW

In 2025, Laboratorio Reig Jofre's return on assets (ROA) was 0.03, a 5.79% increase from the 0.03 ROA in the previous year.

Laboratorio Reig Jofre Aktienanalyse

What does Laboratorio Reig Jofre do?

Laboratorio Reig Jofre SA is a leading company in the pharmaceutical industry, specializing in the development, manufacturing, and marketing of drugs. The company was founded in 1929 by the Reig Jofre brothers in Barcelona, Spain. It has since become an international company with a wide portfolio of products and a high level of innovation and quality. The business model of Laboratorio Reig Jofre SA is based on implementing research and innovation in the field of pharmacy. The company has its own R&D department, which collaborates closely with major scientific organizations and universities in Spain to understand and apply the latest developments and innovations in the industry. Laboratorio Reig Jofre SA has three main divisions - human pharmaceuticals, veterinary medicine, and chemical products used in various industries such as cosmetics and food. The human pharmaceutical division includes a variety of products, including prescription drugs, over-the-counter products, and generics, with a focus on therapy areas such as oncology, antibiotics, gynecology, and central nervous system disorders. The veterinary medicine division provides a wide range of vaccines and medications for animal health. The third division of chemical products includes various products such as emulsifiers, preservatives, and natural dyes that can be used in different industries. Some of the most well-known products of Laboratorio Reig Jofre SA include the antibiotic Nitrofurantoin, the analgesic Algiasdin, the hormonal preparation Ovusitol, and the vaccine against Bluetongue in animals. The company has also carried out several successful acquisitions to expand its portfolio and strengthen its international presence. The acquisition of Derivados Quimicos SA (Derma SA) introduced Laboratorio Reig Jofre SA to the skincare sector and strengthened its presence in Latin America. The acquisition of Bioiberica SA introduced the company to the field of bioactive molecules and chondroprotectants. Laboratorio Reig Jofre SA is a company that places quality and innovation at the heart of its activities. The company has a strong corporate culture based on respect, transparency, integrity, and commitment. It has also shown a strong commitment to sustainability and social responsibility, with initiatives such as supporting projects to improve the health of women and children in Africa and implementing environmentally friendly practices in production. Overall, Laboratorio Reig Jofre SA is a leading company in the pharmaceutical industry, capable of offering a wide range of products through research, innovation, and quality. With its diverse portfolio of products and its commitment to sustainability and social responsibility, the company is well-equipped to continue playing a leading role in the industry in the future. Laboratorio Reig Jofre ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Laboratorio Reig Jofre's Return on Assets (ROA)

Laboratorio Reig Jofre's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Laboratorio Reig Jofre's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Laboratorio Reig Jofre's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Laboratorio Reig Jofre’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Laboratorio Reig Jofre stock

What is the Return on Assets (ROA) of Laboratorio Reig Jofre this year?

The Return on Assets (ROA) of Laboratorio Reig Jofre is 0.03 undefined this year.

What was the ROA of Laboratorio Reig Jofre compared to the previous year?

The ROA of Laboratorio Reig Jofre has increased by 5.79% compared to the previous year.

What consequences do high ROA have for investors of Laboratorio Reig Jofre?

A high ROA is advantageous for investors of Laboratorio Reig Jofre, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Laboratorio Reig Jofre?

A low ROA can be unfavorable for investors of Laboratorio Reig Jofre as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Laboratorio Reig Jofre affect the company?

An increase in ROA of Laboratorio Reig Jofre can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Laboratorio Reig Jofre impact the company?

A reduction in the ROA of Laboratorio Reig Jofre can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Laboratorio Reig Jofre?

Some factors that can influence the ROA of Laboratorio Reig Jofre include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Laboratorio Reig Jofre important for investors?

The ROA of Laboratorio Reig Jofre is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Laboratorio Reig Jofre take to improve ROA?

To improve ROA, Laboratorio Reig Jofre can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Laboratorio Reig Jofre pay?

Over the past 12 months, Laboratorio Reig Jofre paid a dividend of 0.04 EUR . This corresponds to a dividend yield of about 1.33 %. For the coming 12 months, Laboratorio Reig Jofre is expected to pay a dividend of 0.03 EUR.

What is the dividend yield of Laboratorio Reig Jofre?

The current dividend yield of Laboratorio Reig Jofre is 1.33 %.

When does Laboratorio Reig Jofre pay dividends?

Laboratorio Reig Jofre pays a quarterly dividend. This is distributed in the months of August, June, June, June.

How secure is the dividend of Laboratorio Reig Jofre?

Laboratorio Reig Jofre paid dividends every year for the past 10 years.

What is the dividend of Laboratorio Reig Jofre?

For the upcoming 12 months, dividends amounting to 0.03 EUR are expected. This corresponds to a dividend yield of 1.12 %.

In which sector is Laboratorio Reig Jofre located?

Laboratorio Reig Jofre is assigned to the 'Health' sector.

Wann musste ich die Aktien von Laboratorio Reig Jofre kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Laboratorio Reig Jofre from 6/26/2025 amounting to 0.049 EUR, you needed to have the stock in your portfolio before the ex-date on 5/15/2025.

When did Laboratorio Reig Jofre pay the last dividend?

The last dividend was paid out on 6/26/2025.

What was the dividend of Laboratorio Reig Jofre in the year 2024?

In the year 2024, Laboratorio Reig Jofre distributed 0.04 EUR as dividends.

In which currency does Laboratorio Reig Jofre pay out the dividend?

The dividends of Laboratorio Reig Jofre are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Laboratorio Reig Jofre

Our stock analysis for Laboratorio Reig Jofre Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratorio Reig Jofre Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.